medigraphic.com
Colegio de Medicina Interna de México.

2018, Number 3

<< Back Next >>

Med Int Mex 2018; 34 (3)

Molecular biology of hepatitis C virus

Dueñas-Carrera S, Acosta-Rivero N, Morales-Grillo J, García-Ferrera WO

Language: Spanish
References: 47
Page: 435-442
PDF size: 434.92 Kb.


ABSTRACT

Infection with hepatitis C virus (HCV), which is distributed worldwide, often becomes in chronic hepatitis, cirrhosis and hepatocellular carcinoma. The HCV genome is a single-stranded RNA molecule of positive polarity approximately 9.6 kb in length. This review summarizes the current knowledge of recent advances in the investigation of the molecular biology of HCV.


REFERENCES

  1. Mayo MA, Pringle CR. Virus taxonomy 1997. J Gen Virol 1998;79(Pt 4):649-657.

  2. Feinstone SM, Mihalik KB, Kimimura T, Alter HJ, London WT y Purcell RH. Inactivation of hepatitis C virus and non-A, non-B hepatitis by chloroform. Infect Immunol 1993;41:816-821.

  3. Takahashi K, Kishimoto S, Yoshizawa H, Okamoto H, Yoshikawa A y Mishiro S. p26 protein and 33 nm particle associated with nucleocapsid of hepatitis C virus recovered from the circulation of infected hosts. Virology 1992;191:431-434.

  4. Prince AM, Huima-Byron T, Parker TS y Levine DM. Visualization of Hepatitis C virions and putative defective interfering particles isolated from low-density lipoproteins. J Virol Hepatitis 1996;3:11-17.

  5. Shimizu YK, Feinstones SM, Kohara M, Purcell RH y Yoshikura H. Hepatitis C Virus: Detection of intracellular virus particles by electron microscopy. Hepatology 1996;23:205-209.

  6. Bukh J, Purcell RH y Miller RH. Sequence analysis of the 5’ noncoding region of hepatitis C virus. Proc Natl Acad Sci USA 1992;89(11):4942-4946.

  7. Honda M, Ping L-H, Rijnbrand RCA, Amphlett E, Clarke B, Rowlands DT y Lemon SM. Structural requirements for initiation of translation by internal ribosome entry within genome-lengh hepatitis C virus RNA. Virology 1996;22:31-42.

  8. Manabe S, Fuke I, Tanishita O, Kaji C, Gomi Y, Yoshida S, Mori C, Takamizawa A, Yosida I, Okayama H. Production of nonstructural proteins of hepatitis C virus requires a putative viral protease encoded by NS3. Virology 1994;198(2):636-644.

  9. Takamizawa A, Mori C, Fuke I, Manabe S, et al. Structure and organization of the hepatitis C virus genome isolate from human carriers. J Virol 1991;65:1105-1113.

  10. Bukh J, Miller RH, Purcell RH. Genetic heterogeneity of hepatitis C virus: quasispecies and genotypes. Semin Liver Dis 1995;15(1):41-63.

  11. Santolini E, Migliaccio G, La monica N. Biosynthesis and biochemical properties of the hepatitis C virus core protein. J Virol 1994;68:3631-3641.

  12. Lo S-Y, Masiarz F, Hwang SB, Lai MMC, Ou J-H. Differential subcellular localization of hepatitis C virus core gene products. Virology 1995;213:455-461.

  13. Acosta-Rivero N, Alvarez-Obregon JC, Musacchio A, Falcon V, Dueñas-Carrera S, Marante J, Menendez I, Morales J. In vitro self-assembled HCV core virus-like particles induce a strong antibody immune response in sheep. Biochem Biophys Res Commun 2002;290(1):300-4.

  14. Acosta-Rivero N, Rodriguez A, Musacchio A, Falcon V, Suarez VM, Martinez G, Guerra I, Paz-Lago D, Morera Y, de la Rosa MC, Morales-Grillo J, Dueñas-Carrera S. In vitro assembly into virus-like particles is an intrinsic quality of Pichia pastoris derived HCV core protein. Biochem Biophys Res Commun 2004;325(1):68-74.

  15. Acosta-Rivero N, Rodriguez A, Mussachio A, Poutu J, et al. A C-terminal truncated hepatitis C virus core protein variant assembles in vitro into virus-like particles in the absence of structured nucleic acids. Biochem Biophys Res Commun 2005;334(3):901-6.

  16. Chang SC, Yen J-H, Kang H-Y, Jang M-H, Chang M-F. Nuclear localization signals in the core protein of hepatitis C virus. Biochem Biophys Res Commun 1994;205(2):1284-1290.

  17. Hwang SB, Lo S-Y, Ou J-H, Lai MMC. Detection of cellular proteins and viral core protein interacting with the 5' untranslated region of hepatitis C virus RNA. J Biomed Sci 1995;2:227-236.

  18. Reed KE, Rince MC. Molecular characterization of hepatitis C virus in hepatitis C virus, Reesink HW (ed). Curr Stud Hematol Blood Transf Basel, Karger 1998;2:1-37.

  19. Acosta-Rivero N, Rodriguez A, Musacchio A, Falcon V, Suarez VM, Chavez L, Morales-Grillo J, Dueñas-Carrera S. Nucleic acid binding properties and intermediates of HCV core protein multimerization in Pichia pastoris. Biochem Biophys Res Commun 2004;323(3):926-31.

  20. Matsumoto M, Hwang SB, Jeng K-S, Zhu N, Lai MMC. Homotypic interaction and multimerization of hepatitis C core protein. Virology 1996;218:43-51.

  21. Moriya K, Fujie H, Shintani Y, Yotsuyanagi H, et al. The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice. Nat Med 1998;4:1065-7.

  22. Marusawa H, Hijikata M, Chiba T, Shimotohno K. Hepatitis C virus core protein inhibits Fas- and tumor necrosis factor alpha-mediated apoptosis via NF-kappaB activation. J Virol 1999;73:4713-20.

  23. Kittlesen DJ, Chianese-Bullock KA, Yao ZQ, Braciale TJ, Hahn YS. Interaction between complement receptor gC1qR and hepatitis C virus core protein inhibits T-lymphocyte proliferation. J Clin Invest 2000;106: 1239-49.

  24. Fournillier A, Cahour A, Escriou N, Girard M, Wychowski C. Processing of the E1 glycoprotein of hepatitis C virus expressed in mammalian cells. J Gen Virol 1996;77:1055- 1064.

  25. Kato N. Molecular virology of hepatitis C virus. Acta Med Okayama 2001;55(3):133-159.

  26. Griffin S, Clarke D, McCormick C, Rowlands D, Harris M. Signal peptide cleavage and internal targeting signals direct the hepatitis C virus p7 protein to distinct intracellular membranes. J Virol 2005;79(24):15525-36.

  27. Rosa D, Campagnoli S, Moretto C, Guenzi E, et al. A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: Cytofluorimetric assessment of envelope glycoprotein 2 binding to target cells. Proc Natl Acad Sci USA 1996;93:1759-1763.

  28. Gorbalenya AE, Snijder EJ. Viral cysteine proteinases. Persp Drug Discov Des 1996;6:64-86.

  29. Steinkühleer C, Tomei L, De Francesco R. In vitro activity of hepatitis C virus NS3 purified from recombinant baculovirus- infected Sf9 cells. J Biol Chem 1996;271:6367-6373.

  30. Kiiver K, Merits A, Ustav M, Zusinaite E. Complex formation between hepatitis C virus NS2 and NS3 proteins. Virus Res. 2005. Publicación electrónica antes de impresión.

  31. Enomoto N, Sakuma I, Asahina Y, Kurosaki M, et al. Comparison of full-length sequences of interferon-sensitive and resistant hepatitis 1b. J Clin Invest 1995;96:224-230.

  32. Kato N. Genome of human hepatitis C virus (HCV): gene organization, sequence diversity, and variation. Microb Comp Genomics 2000;5(3):129-151.

  33. Hwang SB, Park K-J, Kim Y-S, Syng YC, Lai MMC. Hepatitis C virus NS5 B protein is a membrane associated phosphoprotein with a predominantly perinuclear localization. Virology 1997;227:439-446.

  34. Hamamoto I, Nishimura Y, Okamoto T, Aizaki H, et al. Human VAP-B is involved in hepatitis C virus replication through interaction with NS5A and NS5B. J Virol 2005;79(21):13473-82.

  35. Naka K, Dansako H, Kobayashi N, Ikeda M, Kato N. Hepatitis C virus NS5B delays cell cycle progression by inducing interferon-beta via Toll-like receptor 3 signaling pathway without replicating viral genomes. Virology 2005. Publicación electrónica antes de impression.

  36. Bartenschlager R, Lohmann V. Replication of the hepatitis C virus. Baillieres Best Pract Res Clin Gastroenterol 2000;14(2):241-254.

  37. Simmonds P, Bukh J, Combet C, Deleage G, et al. Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology 2005;42(4):962-73.

  38. Zeuzem S. The kinetics of hepatitis C virus infection. Clin Liver Dis 2001;5(4):917-930.

  39. Abe K, Inchauspe G, Fijisawa K. Genomic characterization and mutation rate of hepatitis C virus in patients who contracted hepatitis during an epidemic of NANBH in Japan. J Gen Virol 1992;73:2725-2729.

  40. Alfonso V, Mbayed VA, Sookoian S, Campos RH. Intra-host evolutionary dynamics of hepatitis C virus E2 in treated patients. J Gen Virol 2005;86(Pt 10):2781-6.

  41. Lamelin JP, Zoulim F, Trépo C. Lymphotropism of hepatitis B and C viruses: an update and a newcomor. Int J Clin Lab Res 1995;25:1-6.

  42. Zignego AL, De Carli M, Monti M, Careccia G, et al. Hepatitis C virus infection of mononuclear cells from peripheral blood and liver infiltrates in chronically infected patients. J Med Virol 1995;47:58-64.

  43. Pileri P, Uematsu Y, Campagnoli S, Galli G, et al. Binding of hepatitis C virus to CD81. Science 1998;282:938-941.

  44. Agnello V, Abel G, Elfahal M, Knight GB, Zhang QX. Hepatitis C virus and other flaviviridae viruses enter cells via low-density lipoprotein receptor. Proc Natl Acad Sci USA 1999;96(22):12766-12771.

  45. Lindenbach BD, Rice CM. Unravelling hepatitis C virus replication from genome to function. Nature 2005;436:933- 938.

  46. Blanchard E, Brand D, Trassard S, Goudeau A, Roingeard P. Hepatitis C virus-like particle morphogenesis. J Virol 2002;76(8):4073-4079.

  47. McHutchison JG, Gordon SC, Schiff ER, Shiffman ML, et al. Interferon alfa 2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. N Engl J Med 1998;339:1485-1492.




2020     |     www.medigraphic.com